Clinicopathological characteristics of ovarian carcinomas associated with endometriosis

Archives of Gynecology and Obstetrics

Volumn 285, Issue 2, 2012, Pages 479-483

  Kondi Pafiti, A ^a   Papakonstantinou, E ^b   Iavazzo, C ^b   Grigoriadis, C ^b   Salakos, N ^b   Gregoriou, O ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cancer; Endometrioid ovarian carcinoma; Endometriosis clear cell carcinoma of the ovary; Ovary

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CYST; CYTOREDUCTIVE SURGERY; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; FEMALE; FIBROSIS; GENETIC ASSOCIATION; GREECE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LYMPHADENECTOMY; MACROPHAGE; OMENTECTOMY; OVARY CARCINOMA; PERITONEAL BIOPSY; POSTOPERATIVE CARE; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; STROMA; TREATMENT PLANNING; UNIVERSITY HOSPITAL;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, ENDOMETRIOID; CHEMOTHERAPY, ADJUVANT; ENDOMETRIOSIS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; PACLITAXEL; RETROSPECTIVE STUDIES; SALPINGECTOMY;

EID: 84864424771     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-1957-z     Document Type: Article

References (36)

1. Kaku T, Ogawa S, Kawano Y, Ohishi Y, Kobayashi H, Hirakawa T, Nakano H (2003) Histological classification of ovarian cancer. Med Electron Microsc 36:9-17
2. Kobayashi H, Kajiwara H, Kanayama S, Yamada Y, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T, Oi H (2009) Molecular pathogenesis of endometriosis- associated clear cell carcinoma of the ovary (Review). Oncol Rep 22:233-240
3. Crozier MA, Copeland LJ, Silva EG, Gerhenson DM, Stringer CA (1989) Clear cell carcinoma of the ovary: a study of 59 cases. Gynecol Oncol 35:199-203
4. Varma R, Rollason T, Gupta JK, Maher ER (2004) Endometriosis and the metastatic process. Reproduction 127:293-304
5. Erzen M, Kovacic J (1998) Relationship between endometriosis and ovarian cancer. Eur J Gynaecol Oncol 19:553
6. Kurman RJ, Ellenson LH, Ronnett BM (eds) (2011) Blaustein's pathology of the female genital tract, 6th edn. Springer, New York, pp 647-649
7. Kobayashi H (2009) Ovarian cancer in endometriosis: epidemiology, natural history and clinical diagnosis. Int J Clin Oncol 14:378-382
8. Kobayashi H, Sumimoto K, Kitanaka T et al (2008) Ovarian endometrioma-risk factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol 138:187-193
9. Jimbo H, Yoshikawa H, Onda T et al (1997) Prevalence of ovarian endometriosis in epithelial ovarian cancer. Int J Gynecol Obstet 59:245-250
10. Sugiyama T, Kamura T, Kigawa J, Terakawa N et al (2000) Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88:2584-2589
11. Schiller W (1929) Mesonephroma ovarii. Int J Cancer 35:1
12. Saphir O, Lackner JE (1944) Adenocarcinoma with clear cells (hypernephroid) of ovary. Surg Gynecol Obstet 79:539
13. Teilum G (1946) Gonocytoma: homologous ovarian and testic-ular tumors. Acta Pathol Microbiol Scand 23:242
14. Scully RE (1970) Recent progress in ovarian cancer. Hum Pathol 1:73
15. Scully RE, Barlos JF (1967) Mesonephroma of the ovary: tumor of mullerian nature related to endometrioid carcinoma. Cancer 20:1405
16. Shevchuk MM, Winckler-Monsanto B, Fenoglio CM et al (1981) Clear cell carcinoma of the ovary: a clinicopathologic study with review of the literature. Cancer 47:1344
17. Prowse AH, Manek S, Varma R et al (2006) Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. Int J Cancer 119:556-562
18. Defrere S, Lousse JC, Gonzalez-Ramos R, Colette S, Donnez J, van Langendonckt A (2008) Potential involvement of iron in the pathogenesis of peritoneal endometriosis. Mol Hum Reprod 14:377-385
19. Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K, Fujii S (2008) Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the ironinduced persistent oxidative stress. Clin Cancer Res 14:32-40
20. Zorn KK, Bonome T, Gangi L, Chandramouli GVR, Awtrey CS et al (2005) Gene expression profiles of serous, endometrioid and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res 11(18):6422-6430
21. Yoshida S, Furukawa N, Haruta S, Tanase Y, Kanayama S, Noguchi T et al (2009) Theoretical model of treatment strategies for clear cell carcinoma of the ovary: focus on perspectives. Cancer Treat Rev 35:608-615
22. Kurman RJ, Visvanathan K, Roden R, Shih I-M (2008) Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obst Gynecol 4:351-356
23. Christie M, Oehler MK (2006) Molecular pathology of epithelial ovarian cancer. J Br Menopause Soc 12(2):57-63
24. Kajihara H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sado T, Oi H, Kobayashi H (2010) Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review). Oncol Rep 23(5):1193-1203
25. Kato N, Sasou S, Motoyama T (2006) Expression of hepatocyte nuclear factor 1beta (HNF-1b) in clear cell tumors and endo-metriosis of the ovary. Mod Pathol 19:83-89
26. Skirnisdottir I, Seidal T, Karlsson MG, Sorbe B (2005) Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II. Int J Oncol 26(1):177-183
27. Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, Noguchi M (2000) Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endo-metrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60:7052-7056
28. Kurman RJ, Shih I-M (2008) Pathogenesis of ovarian cancer. Lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 27(2):151-160
29. Keita M, Bessette P, Pelmus M, Ainmelk Y, Aris A (2010) Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes. J Ovarian Res 3:3
30. Castiblanco GA, Pires NY, Wistuba OI, Riquelme SE, Andrade ML, Corvalan RA (2006) Pathogenetic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis. Rev Med Chil 134(3):271-278
31. Jenison EL, Montag AG, Griffiths CT, Welch WR, Lavin PT, Greer J, Knapp RC (1989) Clear cell adenocarcinoma of the ovary: a clinical analysis, comparison with serous carcinoma. Gynecol Oncol 32(1):65-71
32. Takano M, Kikuchi Y, Yaegashi N, Kuzuya K, Ueki M, Tsuda H, Suzuki M et al (2006) Clear cell carcinoma of the ovary: a retrospective multicenter experience of 254 patients with complete surgical staging. Br J Cancer 94:1369-1374
33. Ryu SY, Park SI, Nam BH, Kim I, Yoo CW, Nam JH, Lee KH et al (2009) Prognostic significance of histological grade in clear cell carcinoma of the ovary: a retrospective study of Korean gynecologic oncology group. Ann Oncol 20:1032-1036
34. Behbakht K, Randall TC, Benjamin I, Morgan MA, King S, Rubin SC (1998) Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol 70:255-258
35. Takano M, Sasaki N, Kita T, Kudoh K, Fujii K et al (2008) Survival analysis of ovarian clear cell carcinoma confined to the ovary with or without comprehensive surgical staging. Oncol Rep 19:1259-1264
36. Shi M, Zhang Y, Shen K, Lang J, Huang H, Wu M (2002) Clinical characteristics of clear cell carcinoma of the ovary. Zhonghua Fu Chan Ke Za Zhi 37(3):161-163